| 188 Publications |
This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.
Export
-
1.
2013Timothy Robert Church; Michael Wandell; Catherine Lofton-Day; Steven J Mongin; Matthias Burger; Shannon R Payne; Esmeralda Castaños-Vélez; Brent A Blumenstein; Thomas Rösch; Neal Osborn; et al.
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
Gut. 2013.0 -
2.
2013David F. Ransohoff; Michael Pignone; Harold C. Sox
How to decide whether a clinical practice guideline is trustworthy
JAMA - Journal of the American Medical Association. 2013;309(2):139-140.3 -
3.
2013L. Von Karsa; J. Patnick; N. Segnan; W. Atkin; S. Halloran; I. Lansdorp-Vogelaar; N. Malila; S. Minozzi; S. Moss; P. Quirke; et al.
Endoscopy. 2013;45(1):51-59.1 -
4.
2012Thomas F. Imperiale; Elizabeth A. Glowinski; Ching Lin-Cooper; David F. Ransohoff
Tailoring colorectal cancer screening by considering risk of advanced proximal neoplasia
American Journal of Medicine. 2012;125(12):1181-1187.1 -
5.
2012Jane Zapka; Carrie N. Klabunde; Stephen Taplin; Gigi Yuan; David Ransohoff; Sarah Kobrin
Screening colonoscopy in the US: Attitudes and practices of primary care physicians
Journal of General Internal Medicine. 2012;27(9):1150-1158.2 -
6.
2012Margaret L. Gourlay; Jason P. Fine; John S. Preisser; Ryan C. May; Chenxi Li; Li-Yung Lui; David F. Ransohoff; Jane A. Cauley; Kristine E. Ensrud
Bone-density testing interval and transition to osteoporosis in older women
New England Journal of Medicine. 2012;366(3):225-233.37 -
7.
2012Thomas F. Imperiale; David F. Ransohoff
Annals of Internal Medicine. 2012;156(10):703-709.3 -
8.
2011Otis Brawley; Tim Byers; Amy Chen; Michael Pignone; David Ransohoff; Maryjean Schenk; Robert Smith; Harold Sox; Alan G. Thorson; Richard Wender
New American cancer society process for creating trustworthy cancer screening guidelines
JAMA - Journal of the American Medical Association. 2011;306(22):2495-2499.19 -
9.
2011A. Cecile. J. W. Janssens; John P. A. Ioannidis; Sara Bedrosian; Paolo Boffetta; Siobhan M. Dolan; Nicole Dowling; Isabel Fortier; Andrew N. Freedman; Jeremy M. Grimshaw; Jeffrey Gulcher; et al.
Strengthening the reporting of genetic risk prediction studies (GRIPS): Explanation and elaboration
European Journal of Clinical Investigation. 2011;41(9):1010-1035.3 -
10.
2011David F. Ransohoff; Bonnie Yankaskas; Ziya Gizlice; Lisa Gangarosa
Recommendations for post-polypectomy surveillance in community practice
Digestive Diseases and Sciences. 2011;56(9):2623-2630.8 -
11.
2011A. Cecile J.W. Janssens; John P.A. Ioannidis; Sara Bedrosian; Paolo Boffetta; Siobhan M. Dolan; Nicole Dowling; Isabel Fortier; Andrew N. Freedman; Jeremy M. Grimshaw; Jeffrey Gulcher; et al.
Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): Explanation and elaboration
Journal of Clinical Epidemiology. 2011;64(8):e1-e22.2 -
12.
2011Michael Pignone; David F. Ransohoff
Cross-model comparisons to improve the value of modeling: The case of colorectal cancer screening
Medical Decision Making. 2011;31(4):524-526.2 -
13.
2011David F. Ransohoff; Michael Pignone; Louise B. Russell
Using models to make policy: An inflection point?
Medical Decision Making. 2011;31(4):527-529.1 -
14.
2011A Cecile J.W. Janssens; John P.A. Ioannidis; Sara Bedrosian; Paolo Boffetta; Siobhan M. Dolan; Nicole Dowling; Isabel Fortier; Andrew N. Freedman; Jeremy M. Grimshaw; Jeffrey Gulcher; et al.
Strengthening the reporting of genetic risk prediction studies (GRIPS): Explanation and elaboration
European Journal of Human Genetics. 2011;19(5):493.1 -
15.
2011A Cecile J W Janssens; John P A Ioannidis; Sara Bedrosian; Paolo Boffetta; Siobhan M Dolan; Nicole Dowling; Isabel Fortier; Andrew N Freedman; Jeremy M Grimshaw; Jeffrey Gulcher; et al.
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.
European journal of human genetics : EJHG. 2011;19(5):18 p preceding 494.1 -
16.
2011A. Cecile J. W. Janssens; John P. A. Ioannidis; Sara Bedrosian; Paolo Boffetta; Siobhan M. Dolan; Nicole Dowling; Isabel Fortier; Andrew N. Freedman; Jeremy M. Grimshaw; Jeffrey Gulcher; et al.
Strengthening the reporting of genetic risk prediction studies (GRIPS): Explanation and elaboration
European Journal of Epidemiology. 2011;26(4):313-337.5 -
17.
2011Fabrice Andre; Lisa M. McShane; Stefan Michiels; David F. Ransohoff; Douglas G. Altman; Jorge S. Reis-Filho; Daniel F. Hayes; Lajos Pusztai
Biomarker studies: A call for a comprehensive biomarker study registry
Nature Reviews Clinical Oncology. 2011;8(3):171-176.22 -
18.
2011Claire S. Zhu; Paul F. Pinsky; Daniel W. Cramer; David F. Ransohoff; Patricia Hartge; Ruth M. Pfeiffer; Nicole Urban; Gil Mor; Robert C. Bast Jr.; Lee E. Moore; et al.
Cancer Prevention Research. 2011;4(3):375-383.53 -
19.
2010V. Paul Doria-Rose; Chris Vinden; David F. Ransohoff; Philip C. Prorok
Flexible sigmoidoscopy to prevent colorectal cancer
The Lancet. 2010;376(9744):871.1 -
20.
2010Jennifer M. Croswell; David F. Ransohoff; Barnett S. Kramer
Principles of cancer screening: Lessons from history and study design issues
Seminars in Oncology. 2010;37(3):202-215.23 -
21.
2010Thomas F. Imperiale; David F. Ransohoff
Understanding Differences in the Guidelines for Colorectal Cancer Screening
Gastroenterology. 2010;138(5):1642-1647.e1.8 -
22.
2010Henry Rodriguez; Živana Težak; Mehdi Mesri; Steven A. Carr; Daniel C. Liebler; Susan J. Fisher; Paul Tempst; Tara Hiltke; Larry G. Kessler; Christopher R. Kinsinger; et al.
Clinical Chemistry. 2010;56(2):237-243.28 -
23.
2010David F. Ransohoff; Margaret L. Gourlay
Sources of bias in specimens for research about molecular markers for cancer
Journal of Clinical Oncology. 2010;28(4):698-704.52 -
24.
2010Fred E. Regnier; Steven J. Skates; Mehdi Mesri; Henry Rodriguez; Živana Težak; Marina V. Kondratovich; Michail A. Alterman; Joshua D. Levin; Donna Roscoe; Eugene Reilly; et al.
Protein-based multiplex assays: Mock presubmissions to the US food and drug administration
Clinical Chemistry. 2010;56(2):165-171.25 -
25.
2010David F. Ransohoff
Proteomics research to discover markers: What can we learn from netflix®?
Clinical Chemistry. 2010;56(2):172-176.10 -
26.
2010David F Ransohoff
Can endoscopy protect against colorectal cancer? An RCT
The Lancet. 2010;375(9726):1582-1584.4 -
27.
2010D.F. Ransohoff; M.J. Khoury
Personal genomics: Information can be harmful
European Journal of Clinical Investigation. 2010;40(1):64-68.32 -
28.
2009René Lambert; Shin ei Kudo; Michael Vieth; John I. Allen; Hiroaki Fujii; Takahiro Fujii; Hiroshi Kashida; Takahisa Matsuda; Masaki Mori; Hiroshi Saito; et al.
Pragmatic classification of superficial neoplastic colorectal lesions
Gastrointestinal Endoscopy. 2009;70(6):1182-1199.25 -
29.
2009Terri A. Addona; Susan E. Abbatiello; Birgit Schilling; Steven J. Skates; D.R. Mani; David M. Bunk; Clifford H. Spiegelman; Lisa J. Zimmerman; Amy-Joan L. Ham; Hasmik Keshishian; et al.
Nature Biotechnology. 2009;27(9):864.0 -
30.
2009Muin J. Khoury; Colleen M. McBride; Sheri D. Schully; John P. A. Ioannidis; W Gregory Feero; A Cecile J. W. Janssens; Marta Gwinn; Denise G. Simons-Morton; Jay M. Bernhardt; Michele Cargill; et al.
Genetics in Medicine. 2009;11(8):559-567.95 -
31.
2009Terri A. Addona; Susan E. Abbatiello; Birgit Schilling; Steven J. Skates; D.R. Mani; David M. Bunk; Clifford H. Spiegelman; Lisa J. Zimmerman; Amy-Joan L. Ham; Hasmik Keshishian; et al.
Nature Biotechnology. 2009;27(7):633-641.293 -
32.
2009Joan L. Warren; Carrie N. Klabunde; Angela B. Mariotto; Angela Meekins; Marie Topor; Martin L. Brown; David F. Ransohoff
Adverse events after outpatient colonoscopy in the Medicare population
Annals of Internal Medicine. 2009;150(12):849-857.82 -
33.
2009Thomas F. Imperiale; Elizabeth A. Glowinski; Beth E. Juliar; Faouzi Azzouz; David F. Ransohoff
Variation in polyp detection rates at screening colonoscopy
Gastrointestinal Endoscopy. 2009;69(7):1288-1295.45 -
34.
2009J.-C. Saurin; T.F. Imperiale; E.A. Glowinski; C. Lin-Cooper; G.N. Larkin; J.D. Rogge; D.F. Ransohoff
Five-Year risk of colorectal neoplasia after negative screening colonoscopy
Acta Endoscopica. 2009;39(2):114-115.0 -
35.
2009Thomas F. Imperiale; Elizabeth A. Glowinski; Ching Lin-Cooper; Gregory N. Larkin; James D. Rogge; David F. Ransohoff
Five-Year risk of colorectal neoplasia after negative screening colonoscopy
Obstetrical and Gynecological Survey. 2009;64(2):113-114.0 -
36.
2009David F. Ransohoff
How much does colonoscopy reduce colon cancer mortality?
Annals of Internal Medicine. 2009;150(1):50-52.38 -
37.
2009David F Ransohoff
Promises and limitations of biomarkers.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer. 2009;181:55-59.8 -
38.
2008Thomas F. Imperiale; David F. Ransohoff
New England Journal of Medicine. 2008;359(24):2612.0 -
39.
2008David F. Ransohoff
The process to discover and develop biomarkers for cancer: A work in progress
Journal of the National Cancer Institute. 2008;100(20):1419-1420.11 -
40.
2008Shin ei Kudo; René Lambert; John I. Allen; Hiroaki Fujii; Takahiro Fujii; Hiroshi Kashida; Takahisa Matsuda; Masaki Mori; Hiroshi Saito; Tadakazu Shimoda; et al.
Nonpolypoid neoplastic lesions of the colorectal mucosa
Gastrointestinal Endoscopy. 2008;68(4 SUPPL.):S3-S47.97 -
41.
2008Thomas F. Imperiale; Elizabeth A. Glowinski; Ching Lin-Cooper; Gregory N. Larkin; James D. Rogge; David F. Ransohoff
Five-year risk of colorectal neoplasia after negative screening colonoscopy
New England Journal of Medicine. 2008;359(12):1218-1224.94 -
42.
2008Ann G Zauber; Theodore R Levin; C Carl Jaffe; Barbara A Galen; David F Ransohoff; Martin L Brown
Implications of new colorectal cancer screening technologies for primary care practice.
Medical care. 2008;46(9 Suppl 1):S138-146.5 -
43.
2008David F. Ransohoff; Christopher Martin; Wesley S. Wiggins; Ben A. Hitt; Temitope O. Keku; Joseph A. Galanko; Robert S. Sandler
Assessment of serum proteomics to detect large colon adenomas
Cancer Epidemiology Biomarkers and Prevention. 2008;17(8):2188-2193.12 -
44.
2008Anna P. Schenck; Carrie N. Klabunde; Joan L. Warren; Sharon Peacock; William W. Davis; Sarah T. Hawley; Michael Pignone; David F. Ransohoff
Cancer Epidemiology Biomarkers and Prevention. 2008;17(4):799-804.16 -
45.
20070 -
46.
2007David F. Ransohoff
Journal of Clinical Epidemiology. 2007;60(12):1205-1219.71 -
47.
2007H. Gilbert Welch; Steven Woloshin; Lisa M. Schwartz; Leon Gordis; Peter C. Gøtzsche; Russell Harris; Barnett S. Kramer; David F. Ransohoff
Archives of Internal Medicine. 2007;167(21):2289-2295.40 -
48.
2007David F. Ransohoff
What is the role of iFOBT in screening for colorectal cancer?
Gut. 2007;56(10):1343-1344.3 -
49.
2007James E. Allison; Lori C. Sakoda; Theodore R. Levin; Jo P. Tucker; Irene S. Tekawa; Thomas Cuff; Mary Pat Pauly; Lyle Shlager; Albert M. Palitz; Wei K. Zhao; et al.
Journal of the National Cancer Institute. 2007;99(19):1462-1470.137 -
50.
2007Anna P. Schenck; Carrie N. Klabunde; Joan L. Warren; Sharon Peacock; William W. Davis; Sarah T. Hawley; Michael Pignone; David F. Ransohoff
Data sources for measuring colorectal endoscopy use among medicare enrollees
Cancer Epidemiology Biomarkers and Prevention. 2007;16(10):2118-2127.31 -
51.
2007Carrie N. Klabunde; David Lanier; Erica S. Breslau; Jane G. Zapka; Robert H. Fletcher; David F. Ransohoff; Sidney J. Winawer
Journal of General Internal Medicine. 2007;22(8):1195-1205.53 -
52.
2007David Lieberman; Marion Nadel; Robert A. Smith; Wendy Atkin; Subash B. Duggirala; Robert Fletcher; Seth N. Glick; C. Daniel Johnson; Theodore R. Levin; John B. Pope; et al.
Gastrointestinal Endoscopy. 2007;65(6):757-766.96 -
53.
2007Robert H. Fletcher; David F. Ransohoff; Thomas F. Imperiale
Cancer. 2007;109(9):1925-1926.0 -
54.
2006David F. Ransohoff; Marshall H. Chin; Frederic C. Blow; Bernadine Cimprich; Lawrence Friedman; Christine Laine; William F. Renn; Elena V. Rios; Mary E. Ropka; Anita L. Sabichi; et al.
Annals of Internal Medicine. 2006;145(11):839-844.60 -
55.
2006Frank L. Meyskens Jr.; David F. Ransohoff
Predicting risk for the appearance of melanoma
Journal of Clinical Oncology. 2006;24(22):3522-3523.3 -
56.
2006Steven H. Woolf; David F. Ransohoff; Alex H. Krist
Reader responses to colonoscopy versus sigmoidoscopy [3]
Family Medicine. 2006;38(5):311-312.0 -
57.
200517 -
58.
2005David F Ransohoff
The American journal of gastroenterology. 2005;100(9):1905-1907; discussion 1907-1908.25 -
59.
2005Douglas K. Rex; David F. Ransohoff; Edgar Achkar
DEBATE: Colonoscopy is justified for any polyp discovered during computed tomographic colonography
American Journal of Gastroenterology. 2005;100(9):1903-1908.13 -
60.
2005Graeme P. Young; Daniel L. Worthley; Thomas F. Imperiale; David F. Ransohoff; Steven H. Itzkowitz
Screening with a fecal multitarget DNA test
Gastroenterology. 2005;129(2):757-759.1 -
61.
2005Ronghui Xu; Anthony Gamst; David F. Ransohoff
Re: Lessons from controversy: Ovarian cancer screening and serum proteomics (multiple letters) [2]
Journal of the National Cancer Institute. 2005;97(16):1226-1227.2 -
62.
2005J. Patnick; D. Ransohoff; W. Atkin; J. Ma Borras; M. Elwood; G. Hoff; M. Nadel; A. Russo; J. Simon; E. Weiderpass; et al.
Annals of Oncology. 2005;16(6):993.0 -
63.
2005Isaac M. Lipkus; Celette Sugg Skinner; John Dement; Lisa Pompeii; Barry Moser; Gregory P. Samsa; David Ransohoff
Preventive Medicine. 2005;40(5):489-501.23 -
64.
2005David F. Ransohoff
Colon cancer screening in 2005: Status and challenges
Gastroenterology. 2005;128(6):1685-1695.88 -
65.
2005T.F. Imperiale; D.F. Ransohoff; S.H. Itzkowitz; B.A. Turnbull; M.E. Ross; Philip S. Schoenfeld
Fecal DNA testing: The future of colorectal cancer screening?
Evidence-Based Gastroenterology. 2005;6(2):40-41.0 -
66.
2005R. Iannaccone; A. Laghi; C. Catalano; David F. Ransohoff
Evidence-Based Medicine. 2005;10(2):55.0 -
67.
2005Jean-Louis Frossard; Raymond De Peyer; Daniel L. Worthley; Stephen R. Cole; Graeme P. Young; Thomas F. Imperiale; David F. Ransohoff; Steven H. Itzkowitz
Fecal DNA for colorectal-cancer screening [3] (multiple letters)
New England Journal of Medicine. 2005;352(13):1384-1385.1 -
68.
2005David F. Ransohoff
Lessons from controversy: Ovarian cancer screening and serum proteomics
Journal of the National Cancer Institute. 2005;97(4):315-319.176 -
69.
2005David F. Ransohoff
Bias as a threat to the validity of cancer molecular-marker research
Nature Reviews Cancer. 2005;5(2):142-149.264 -
70.
2005Marion R. Nadel; Jean A. Shapiro; Carrie N. Klabunde; Laura C. Seeff; Robert Uhler; Robert A. Smith; David F. Ransohoff
A national survey of primary care physicians' methods for screening for fecal occult blood
Annals of Internal Medicine. 2005;142(2):86-94+I-26.120 -
71.
2005J. Patnick; D. Ransohoff; W. Atkin; J. Ma Borras; M. Elwood; G. Hoff; M. Nadel; A. Russo; J. Simon; E. Weiderpass-Vaino; et al.
Annals of Oncology. 2005;16(1):34-37.3 -
72.
2004Thomas F. Imperiale; David F. Ransohoff; Steven H. Itzkowitz; Barry A. Turnbull; Michael E. Ross
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population
New England Journal of Medicine. 2004;351(26):2704-2714.397 -
73.
2004David F. Ransohoff
Evaluating discovery-based research: When biologic reasoning cannot work
Gastroenterology. 2004;127(4):1028.13 -
74.
2004Jacques Van Dam; Peter Cotton; C. Daniel Johnson; Beth G. McFarland; Benoit C. Pineau; Dawn Provenzale; David Ransohoff; Douglas Rex; Don Rockey; et al.
AGA future trends report: CT colonography
Gastroenterology. 2004;127(3):970-984.83 -
75.
2004Pauline A. Mysliwiec; Martin L. Brown; Carrie N. Klabunde; David F. Ransohoff
Annals of Internal Medicine. 2004;141(4):264-271+I.179 -
76.
2004David F. Ransohoff
Virtual Colonoscopy - What It Can Do vs What It Will Do
Journal of the American Medical Association. 2004;291(14):1772-1774.30 -
77.
2004David F. Ransohoff
Rules of evidence for cancer molecular-marker discovery and validation
Nature Reviews Cancer. 2004;4(4):309-314.301 -
78.
2004Isaac M. Lipkus; Celette Sugg Skinner; La Sonya G. Green; John Dement; Gregory P. Samsa; David Ransohoff
Modifying attributions of colorectal cancer risk
Cancer Epidemiology Biomarkers and Prevention. 2004;13(4):560-566.12 -
79.
2004Giselle Corbie-Smith; William C. Miller; David F. Ransohoff
Interpretations of 'appropriate' minority inclusion in clinical research
American Journal of Medicine. 2004;116(4):249-252.16 -
80.
2004Jay Onysko; Christina M. Bancej; Carolyn P. Pim; Joann G Elmore; David F. Ransohoff
Journal of the National Cancer Institute. 2004;96(3):238.0 -
81.
2003Thomas F. Imperiale; David R. Wagner; Ching Y. Lin; Gregory N. Larkin; James D. Rogge; David F. Ransohoff
Annals of Internal Medicine. 2003;139(12):959-965+I10.83 -
82.
2003Isaac M. Lipkus; Gregory P. Samsa; John Dement; Celette Sugg Skinner; La Sonya G. Green; Lisa Pompeii; David F. Ransohoff
Preventive Medicine. 2003;37(5):513-519.17 -
83.
2003Joann G. Elmore; Connie Y. Nakano; Thomas D. Koepsell; Laurel M. Desnick; Carl J. D'Orsi; David F. Ransohoff
International variation in screening mammography interpretations in community-based programs
Journal of the National Cancer Institute. 2003;95(18):1384-1393.82 -
84.
20038 -
85.
2003Marco H. Blanker; Siep Thomas; David F. Ransohoff; Mary McNaughton Collins; Floyd J. Fowler Jr.
Reason to screen for prostate cancer based on selective referencing [1] (multiple letters)
American Journal of Medicine. 2003;114(8):706.0 -
86.
2003Giselle Corbie-Smith; Diane Marie M. St. George; Sandra Moody-Ayers; David F. Ransohoff
Adequacy of reporting race/ethnicity in clinical trials in areas of health disparities
Journal of Clinical Epidemiology. 2003;56(5):416-420.41 -
87.
2003David F Ransohoff
Gene-expression signatures in breast cancer.
The New England journal of medicine. 2003;348(17):1715-1717; author reply 1715.1 -
88.
2003Peter Helmbold; Johannes Haerting; Heinz Kölbl; Daniel B. Kopans; Ian H. Kunkler; David F. Ransohoff; Marc J. Van de Vijver; Yudong D. He; Laura J. Van'T Veer; René Bernards
Gene-expression signatures in breast cancer [1] (multiple letters)
New England Journal of Medicine. 2003;348(17):1715-1717.7 -
89.
200345 -
90.
2002David F. Ransohoff
Screening colonoscopy in balance issues of implementation
Gastroenterology Clinics of North America. 2002;31(4):1031-1044.13 -
91.
2002David F. Ransohoff; Mary McNaughton Collins; Floyd J. Fowler Jr.
American Journal of Medicine. 2002;113(8):663-667.80 -
92.
2002David F. Ransohoff
Challenges and opportunities in evaluating diagnostic tests
Journal of Clinical Epidemiology. 2002;55(12):1178-1182.20 -
93.
2002Sidney Cohen; Bruce R. Bacon; Jesse A. Berlin; David Fleischer; Gail A. Hecht; Patrick J. Loehrer Sr.; Alfred E. McNair Jr.; Michael Mulholland; Nancy J. Norton; Linda Rabeneck; et al.
Gastrointestinal Endoscopy. 2002;56(6):803-809.88 -
94.
2002Joseph Romagnuolo; Howard T. Chatterton; Thomas F. Imperiale; David F. Ransohoff
Screening colonoscopy among persons 40 to 49 years of age [1] (multiple letters)
New England Journal of Medicine. 2002;347(15):1205-1206.0 -
95.
2002Mark B. Pochapin; Anthony J. DiMarino Jr.; David F. Ransohoff
Colon cancer screening: January 2002 - Live event
Medical Crossfire. 2002;4(7):23-24+29.0 -
96.
2002David F. Ransohoff; Giovanni Traverso; Kenneth W. Kinzler; Bert Vogelstein
Fecal DNA tests for colorectal cancer [1] (multiple letters)
New England Journal of Medicine. 2002;346(24):1912-1913.2 -
97.
2002Thomas F. Imperiale; David R. Wagner; Ching Y. Lin; Gregory N. Larkin; James D. Rogge; David F. Ransohoff
Results of screening colonoscopy among persons 40 to 49 years of age
New England Journal of Medicine. 2002;346(23):1781-1785.199 -
98.
2002William F. Maule; John F. Bruzzi; Darren D. Brennan; Helen M. Fenlon; Amit Sood; Richa Sood; David F. Ransohoff; Robert S. Sandler
Screening for colorectal cancer [4] (multiple letters)
New England Journal of Medicine. 2002;346(21):1672-1674.6 -
99.
2002Nicholas Shaheen; David F. Ransohoff
Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: Scientific review
Journal of the American Medical Association. 2002;287(15):1972-1981.275 -
100.
2002Nicholas Shaheen; David F. Ransohoff
Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: Clinical applications
Journal of the American Medical Association. 2002;287(15):1982-1986.51 -
101.
2002David F. Ransohoff
Lessons from the UK sigmoidoscopy screening trial
Lancet. 2002;359(9314):1266-1267.21 -
102.
2002David F. Ransohoff; Robert S. Sandler
Screening for colorectal cancer
New England Journal of Medicine. 2002;346(1):40-44.144 -
103.
2002David F. Ransohoff
Research opportunity at the interface of molecular biology and clinical epidemiology
Gastroenterology. 2002;122(5):1199.7 -
104.
2001Olivia Silber Ashley; Marion Nadel; David F. Ransohoff
Achieving quality in flexible sigmoidoscopy screening for colorectal cancer
American Journal of Medicine. 2001;111(8):643-653.17 -
105.
2001M.S. O'Malley; N.J. Shaheen; M.A. Crosby; S.C. Murray; J.S. Klenzak; J.A. Galanko; A. Singla; D.F. Ransohoff; R.S. Sandler; J. Gaither; et al.
Colorectal cancer screening in North Carolina. Community clinicians' perspectives.
North Carolina medical journal. 2001;62(5):292-297.1 -
106.
2001D.F. Ransohoff; R.M. Ransohoff
Sensationalism in the media: when scientists and journalists may be complicit collaborators.
Effective clinical practice : ECP. 2001;4(4):185-188.28 -
107.
2001J.E. Allison; D.F. Ransohoff; M. Pignone; J.S. Mandel; T.R. Church; F. Ederer
New England Journal of Medicine. 2001;344(13):1022-1023.1 -
108.
2000Robert C. Sherrick; Kevin O'Brien; Robert O'Connell; Michael O'Connell; Mark J. Ault; Susan A. Mandel; Charles P. Theuer; Thomas H. Taylor; Hoda Anton-Culver; David Lieberman; et al.
Screening for colorectal cancer [1] (multiple letters)
New England Journal of Medicine. 2000;343(22):1651-1654.9 -
109.
2000Thomas F. Imperiale; David R. Wagner; Ching Y. Lin; Gregory N. Larkin; James D. Rogge; David F. Ransohoff
New England Journal of Medicine. 2000;343(3):169-174.682 -
110.
2000E.J. Volpintesta; N.J. Shaheen; D.F. Ransohoff
Sigmoidoscopy costs and the limits of altruism (multiple letters) [1]
American Journal of Medicine. 2000;108(6):515.0 -
111.
2000Nicholas J Shaheen; Melissa A Crosby; Michael S O'Malley; Sharon C Murray; Robert S Sandler; Joseph A Galanko; David F Ransohoff; Jennifer S Klenzak
American Journal of Gastroenterology. 2000;95(11):3259-3265.13 -
112.
2000James F Helm; Mark W Russo; Andrea K Biddle; Kit N Simpson; David F Ransohoff; Robert S Sandler
American Journal of Gastroenterology. 2000;95(11):3250-3258.22 -
113.
1999N.J. Shaheen; D.F. Ransohoff
Sigmoidoscopy costs and the limits of altruism
American Journal of Medicine. 1999;107(3):286-287.8 -
114.
1999B.D. Cash; P.S. Schoenfeld; D.F. Ransohoff
Licensure, use, and training of paramedical personnel to perform screening flexible sigmoidoscopy
Gastrointestinal Endoscopy. 1999;49(2):163-169.37 -
115.
19998 -
116.
1999P.S. Schoenfeld; B. Cash; J. Kita; M. Piorkowski; D. Cruess; D. Ransohoff
Gastrointestinal Endoscopy. 1999;49(2):158-162.61 -
117.
1999John P. Hunt; Christopher C. Baker; Samir M. Fakhry; Robert R. Rutledge; David Ransohoff; Anthony A. Meyer
Accuracy of administrative data in trauma
Surgery. 1999;126(2):191-197.28 -
118.
1998Christopher A. Lang; David F. Ransohoff
What can we conclude from the randomized controlled trials of fecal occult blood test screening?
European Journal of Gastroenterology and Hepatology. 1998;10(3):199-204.13 -
119.
1997David F. Ransohoff; Russell P. Harris
Lessons from the mammography screening controversy: Can we improve the debate?
Annals of Internal Medicine. 1997;127(11):1029-1034.40 -
120.
1997Mary McNaughton Collins; David F. Ransohoff; Michael J. Barry
Early detection of prostate cancer: Serendipity strikes again
Journal of the American Medical Association. 1997;278(18):1516-1519.43 -
121.
1997D.F. Ransohoff; C.A. Lang; G.P. Young
Colorectal cancer screening: clinical guidelines and rationale.
Gastroenterology. 1997;113(4):1423-1424.5 -
122.
1997C.A. Lang; D.F. Ransohoff
On the sensitivity of fecal occult blood test screening for colorectal cancer.
Journal of the National Cancer Institute. 1997;89(19):1392-1393.2 -
123.
1997David F. Ransohoff; Christopher A. Lang
Screening for colorectal cancer with the fecal occult blood test: A background paper
Annals of Internal Medicine. 1997;126(10):811-822.135 -
124.
1997Sr. John D.J.B.; F.A. Macrae; G.P. Young; F.E. Von Eyben; C. Thordal; D.F. Ransohoff; C.A. Lang; L.M. Miller
Colorectal cancer screening: Clinical guidelines and rationale (multiple letters)
Gastroenterology. 1997;113(4):1422-1424.3 -
125.
1997D.F. Ransohoff; C.A. Lang; G.E. Thibault; J.R. Feussner; M.J. Audet A.-; Jr. Friesinger G.C.; D.L. Kent; K.I. Marton; V.A. Palda; et al.
Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening
Annals of Internal Medicine. 1997;126(10):808-810.40 -
126.
1996Daniel P. Otchy; David F. Ransohoff; Bruce G. Wolff; Amy Weaver; Duane Ilstrup; Harley Carlson; Diana Rademacher
Metachronous colon cancer in persons who have had a large adenomatous polyp
American Journal of Gastroenterology. 1996;91(3):448-454.49 -
127.
1996D.F. Ransohoff; C.A. Lang
Improving the fecal occult-blood test
New England Journal of Medicine. 1996;334(3):189-190.17 -
128.
1996J.E. Allison; I.S. Tekawa; L.J. Ransom; A.L. Adrain; D.F. Ransohoff; C.A. Lang
Improving the fecal occult-blood test [2]
New England Journal of Medicine. 1996;334(24):1607-1608.4 -
129.
1995R.S. Sandler; J. Everhart; F. Fenster; D. Jensen; J. Johanson; D. Lieberman; L. McMahon; D. Provenzale; L. Rabeneck; D. Ransohoff
Gastroenterology. 1995;109(1):302-306.17 -
130.
1995G.M. Eisen; R.S. Sandler; J.I. Wurzelmann; D.F. Ransohoff; A. Talal
Evaluating risk: A primer for gastroenterologists
American Journal of Gastroenterology. 1995;90(5):704-707.7 -
131.
1995D.F. Ransohoff; C.K. McSherry
Why are cholecystectomy rates increasing?
Journal of the American Medical Association. 1995;273(20):1621-1622.9 -
132.
1994Christopher A. Lang; David F. Ransohoff
Journal of the American Medical Association. 1994;271(13):1011-1013.96 -
133.
1994P.B. Cotton; S.C. Chung; W.Z. Davis; R.M. Gibson; D.F. Ransohoff; S.M. Strasberg
Issues in cholecystectomy and management of duct stones
American Journal of Gastroenterology. 1994;89(8 SUPPL.):S169-S176.32 -
134.
1994D.F. Ransohoff
Helicobacter pylori and duodenal ulcer, gastric cancer, and nonulcer dyspepsia: A review
Annals of Internal Medicine. 1994;120(10 SUPPL. 3):62-63.0 -
135.
1994L. Perez-Machado; D.F. Ransohoff; W.A. Gracie
Is gallbladder function a predictor of outcome? [4]
Annals of Internal Medicine. 1994;120(6):523-524.0 -
136.
1994D.F. Ransohoff; C.A. Lang
Using colonoscopy to screen for colorectal cancer
American Journal of Gastroenterology. 1994;89(10):1765-1766.8 -
137.
1994J.S. Mandel; F. Ederer; T. Church; J. Bond; L.M. Pickover; M.S. Sakamoto; J.M. Schlumpberger; C.A. Lang; D.F. Ransohoff
Screening for colorectal cancer: Which test is best? [1]
Journal of the American Medical Association. 1994;272(14):1099-1100.11 -
138.
19930 -
139.
1993J.G. Wright; A.J. McGeer; D. Chyatte; D.F. Ransohoff
Exposure rates to patients' blood for surgical personnel
Surgery. 1993;114(5):897-901.8 -
140.
1993L.J. White; D.F. Ransohoff; W.A. Gracie; J.P. Schmittner; E.L. Mazzaferri; J.R. Feussner; E.J. Huth; G.R. Kerby; F.J. Klocke; A.G. Mulley Jr.; et al.
Guidelines for the treatment of gallstones
Annals of Internal Medicine. 1993;119(7 I):620-622.16 -
141.
1993D.F. Ransohoff; C.A. Lang
Sigmoidoscopic screening in the 1990s
Journal of the American Medical Association. 1993;269(10):1278-1281.41 -
142.
1993D.F. Ransohoff; W.A. Gracie
Annals of Internal Medicine. 1993;119(7 I):606-619.99 -
143.
1993N.J. Talley; O. Nyren; D.A. Drossman; K.W. Heaton; S.J.O. Veldhuyzen Van Zanten; M.M. Koch; D.F. Ransohoff
The irritable bowel syndrome: Toward optimal design of controlled treatment trials
Gastroenterology International. 1993;6(4):189-211.42 -
144.
1992W.C. Beck; J.G. Wright; D.F. Ransohoff
Glove tears and sharp injuries in surgical personnel [7]
Journal of the American Medical Association. 1992;267(7):934.0 -
145.
1992J.A. Nelson; D.F. Ransohoff; C. Lang
Screening for colorectal cancer
Investigative Radiology. 1992;27(7):565.0 -
146.
1991J.G. Wright; A.J. McGeer; D. Chyatte; D.F. Ransohoff
Mechanisms of glove tears and sharp injuries among surgical personnel
Journal of the American Medical Association. 1991;266(12):1668-1671.34 -
147.
1991D.F. Ransohoff; C.A. Lang; H.S. Kuo
Colonoscopic surveillance after polypectomy: Considerations of cost effectiveness
Annals of Internal Medicine. 1991;114(3):177-182.50 -
148.
1991L. Rabeneck; D.F. Ransohoff
Is Helicobacter pylori a cause of duodenal ulcer? A methodologic critique of current evidence
American Journal of Medicine. 1991;91(6):566-572.14 -
149.
1991J.J. De Cosse; J.S. Jacobson; A.M. Shamsuddin; J.T. Ferrucci; J.N. Cooper; K. O'Connor; S.J. Winawer; D.F. Ransohoff; C.A. Lang
Screening for colorectal cancer [2]
New England Journal of Medicine. 1991;326(2):134-137.2 -
150.
1991D.F. Ransohoff; C.A. Lang
Current concepts: Screening for colorectal cancer
New England Journal of Medicine. 1991;325(1):37-41.67 -
151.
1991D.F. Ransohoff
Antibiotic prophylaxis for peritonitis in cirrhosis
Annals of Internal Medicine. 1991;114(SUPPL. 3):79.0 -
152.
19900 -
153.
1990D.F. Ransohoff; W.A. Gracie
Management of patients with symptomatic gallstones: A quantitative analysis
American Journal of Medicine. 1990;88(2):154-160.18 -
154.
1990R.I. Horwitz; C.M. Viscoli; L. Berkman; R.M. Donaldson; S.M. Horwitz; C.J. Murray; D.F. Ransohoff; J. Sindelar
Treatment adherence and risk of death after a myocardial infarction
Lancet. 1990;336(8714):542-545.253 -
155.
1990D.O. Castell; R.G. Blankenbaker; E.M. Bozymski; G.B. Bulkley; M.M. Ravitch; J.D. Elashoff; J.T. Galambos; J.W. Harmon; M. Knauer; S. Krishnamurthy; et al.
Consensus statement on therapeutic endoscopy and bleeding ulcers
Gastrointestinal Endoscopy. 1990;36(5 SUPPL.):S62-S65.35 -
156.
1990A.E. Heald; D.F. Ransohoff
Needlestick injuries among resident physicians
Journal of General Internal Medicine. 1990;5(5):389-393.32 -
157.
1990C.H. King; G. Lombardi; C. Lombardi; R. Greenblatt; S. Hodder; H. Kinyanjui; J. Ouma; O. Odiambo; P.J. Bryan; J. Muruka; et al.
American Journal of Tropical Medicine and Hygiene. 1990;42(6):587-595.16 -
158.
1990D.F. Ransohoff; C.A. Lang
Journal of the American Medical Association. 1990;264(1):76-78.31 -
159.
1989D.O. Castell; R.G. Blankenbaker; E.M. Bozymski; G.B. Bulkley; J.D. Elashoff; J.T. Galambos; J.W. Harmon; C.M. Knauer; S. Krishnamurthy; R.H. Moser; et al.
Therapeutic endoscopy and bleeding ulcers
Journal of the American Medical Association. 1989;262(10):1369-1372.75 -
160.
1988Ralph I. Horwitz; David F. Ransohoff
Epidemiologic methods and methodologic vigilance
Journal of General Internal Medicine. 1988;3(3):298-299.0 -
161.
1988T.F. Imperiale; D.F. Ransohoff
Gastroenterology. 1988;95(6):1670-1676.40 -
162.
1988C.H. King; G. Lombardi; C. Lombardi; R. Greenblatt; S. Hodder; H. Kinyanjui; J. Ouma; O. Odiambo; P.J. Bryan; J. Muruka; et al.
American Journal of Tropical Medicine and Hygiene. 1988;39(3):295-305.38 -
163.
1988J. Sawyer; J. Ellner; D.F. Ransohoff
To biopsy or not to biopsy in suspected herpes simplex encephalitis: A quantitative analysis
Medical Decision Making. 1988;8(2):95-101.11 -
164.
198856 -
165.
1988J.L. Boyer; D.F. Ransohoff
Is colchicine effective therapy for cirrhosis?
New England Journal of Medicine. 1988;318(26):1751-1752.7 -
166.
1987D.F. Ransohoff; G.L. Miller; S.B. Forsythe; R.E. Hermann
Outcome of acute cholecystitis in patients with diabetes mellitus
Annals of Internal Medicine. 1987;106(6):829-832.20 -
167.
1987H. Arbesman; D.F. Ransohoff
Journal of the American Medical Association. 1987;257(4):516-517.29 -
168.
1985David F. Ransohoff; Robert H. Riddell; Bernard Levin
Diseases of the Colon & Rectum. 1985;28(6):383-388.71 -
169.
19850 -
170.
1985D.F. Ransohoff
American Journal of Gastroenterology. 1985;80(6):498-499.0 -
171.
1985D.F. Ransohoff
Biomedical bestiary: An epidemiologic guide to flaws and fallacies in the medical literature
Medical Decision Making. 1985;5(1):105.0 -
172.
1984J.D. Clemens; D.F. Ransohoff
Journal of Chronic Diseases. 1984;37(7):531-544.36 -
173.
1984B. Littenberg; D.F. Ransohoff
Hepatitis B vaccination. Three decision strategies for the individual
American Journal of Medicine. 1984;77(6):1023-1026.0 -
174.
1983Robert H. Riddell; Harvey Goldman; David F. Ransohoff; Henry D. Appelman; Cecilia M. Fenoglio; Rodger C. Haggitt; Christer hren; Pelayo Correa; Stanley R. Hamilton; Basil C. Morson; et al.
Human Pathology. 1983;14(11):931-968.862 -
175.
1983D.F. Ransohoff; W.A. Gracie; L.B. Wolfenson; D. Neuhauser
Annals of Internal Medicine. 1983;99(2):199-204.61 -
176.
1983J.H. Yardley; D.F. Ransohoff; R.H. Riddell; H. Goldman
Cancer in inflammatory bowel disease: How serious is the problem and what should be done about it?
Gastroenterology. 1983;85(1):197-200.4 -
177.
19830 -
178.
1982R.C. Haggitt; H.D. Appelman; P. Correa; C.M. Fenoglio; H. Goldman; S.R. Hamilton; B.C. Morson; D.F. Ransohoff; R.H. Riddell; et al.
Carcinoma or dysplasia in Crohn's disease.
Archives of Pathology and Laboratory Medicine. 1982;106(6):308-309.1 -
179.
1982W.A. Gracie; D.F. Ransohoff
The natural history of silent gallstones. The innocent gallstone is not a myth
New England Journal of Medicine. 1982;307(13):798-800.169 -
180.
1982D.F. Ransohoff; W.A. Muir
Diagnostic workup bias in the evaluation of a test. Serum ferritin and hereditary hemochromatosis
Medical Decision Making. 1982;2(2):139-145.2 -
181.
1982H.J. Dworken; D.F. Ransohoff
Why classify inflammatory bowel disease
Annals of Internal Medicine. 1982;97(2):273-274.0 -
182.
1981D.F. Ransohoff
Real-time ultrasonography in the diagnosis of gallbladder disease
Gastroenterology. 1981;80(4):872-873.0 -
183.
1981D.F. Ransohoff; G. Jacobs
Terminal hepatic failure following a small dose of sulfamethoxazole-trimethoprim
Gastroenterology. 1981;80(4):816-819.18 -
184.
1980D.F. Ransohoff
More on gastric lesions, aspirin, and rheumatic disease
Gastroenterology. 1980;78(4):872-873.0 -
185.
1980David F. Ransohoff
Lactose intolerance and recurrent abdominal pain in childhood
Gastroenterology. 1980;78(1):182.0 -
186.
1978D.F. Ransohoff; A.R. Feinstein
Problems of spectrum and bias in evaluating the efficacy of diagnostic tests
New England Journal of Medicine. 1978;299(17):926-930.626 -
187.
19770 -
188.
1976D.F. Ransohoff; A.R. Feinstein
Is decision analysis useful in clinical medicine?
Yale Journal of Biology and Medicine. 1976;49(2):165-168.7
